goserelin acetate / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
2021-005184-42: Roll-over study to allow continued access to ribociclib

Ongoing
4
137
Europe
ribociclib, Zoladex, Tamoxifeno, LEE011, Film-coated tablet, Implant, Tablet, Kisqali, Goserelin, Tamoxifeno Farmoz
Novartis Pharma AG, Novartis Pharma AG
HR+, HER2- advanced or metastatic breast cancer, advanced or metastatic breast cancer, Diseases [C] - Cancer [C04]
 
 
NCT05161195 / 2021-005184-42: Roll-over Study to Allow Continued Access to Ribociclib

Recruiting
4
137
Europe, Japan, US, RoW
Ribociclib, Letrozole, Anastrozole, Goserelin, Tamoxifen, Fulvestrant
Novartis Pharmaceuticals, Novartis Pharma AG
Metastatic Breast Cancer
02/30
03/30

Download Options